179 related articles for article (PubMed ID: 32804304)
21. Successful therapy of macrophage activation syndrome with dexamethasone palmitate.
Nakagishi Y; Shimizu M; Kasai K; Miyoshi M; Yachie A
Mod Rheumatol; 2016 Jul; 26(4):617-20. PubMed ID: 24754272
[TBL] [Abstract][Full Text] [Related]
22. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
Aoyama-Maeda N; Horino T; Ichii O; Terada Y
Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
[TBL] [Abstract][Full Text] [Related]
23. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
24. Intravenous administration of anakinra in children with macrophage activation syndrome.
Phadke O; Rouster-Stevens K; Giannopoulos H; Chandrakasan S; Prahalad S
Pediatr Rheumatol Online J; 2021 Jun; 19(1):98. PubMed ID: 34187503
[TBL] [Abstract][Full Text] [Related]
25. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.
Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P
Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044
[TBL] [Abstract][Full Text] [Related]
26. Macrophage Activation Syndrome.
Sen ES; Clarke SL; Ramanan AV
Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031
[TBL] [Abstract][Full Text] [Related]
27. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
28. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.
Schulert GS; Grom AA
Annu Rev Med; 2015; 66():145-59. PubMed ID: 25386930
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
31. Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus: case-based review.
Lin Q; Zhang M; Tang H; Shen Y; Zhu Y; Xu Q; Li X
Rheumatol Int; 2020 May; 40(5):811-819. PubMed ID: 31377830
[TBL] [Abstract][Full Text] [Related]
32. Systemic Lupus Erythematosus in Disguise: Acute Pancreatitis as Initial Presentation.
Abughazaleh S; Alsakarneh S; Hattar M; Jaber F; Palmer Q; Ghoz H
J Investig Med High Impact Case Rep; 2023; 11():23247096231185480. PubMed ID: 37421299
[TBL] [Abstract][Full Text] [Related]
33. A case of macrophage activation syndrome successfully treated with anakinra.
Kelly A; Ramanan AV
Nat Clin Pract Rheumatol; 2008 Nov; 4(11):615-20. PubMed ID: 18825135
[TBL] [Abstract][Full Text] [Related]
34. Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis.
Gerstein M; Borgia RE; Dominguez D; Feldman BM; Liao F; Levy DM; Ng L; Abdelhaleem M; Silverman ED; Hiraki LT
J Rheumatol; 2021 Sep; 48(9):1450-1457. PubMed ID: 33262295
[TBL] [Abstract][Full Text] [Related]
35. [Thrombocytosis in a macrophage activation syndrome complicating systemic lupus erythematosus].
Lekpa FK; Ndongo S; Fall S; Pouye A; Ka MM; Moreira-Diop T
Pan Afr Med J; 2014; 19():11. PubMed ID: 25584123
[TBL] [Abstract][Full Text] [Related]
36. Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen.
Xu G; Islam ST; Makarie-Rofail L; Barnsley L; Limaye S
Int J Rheum Dis; 2023 Nov; 26(11):2284-2287. PubMed ID: 37150523
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus associated with development of macrophage activation syndrome and disseminated aspergillosis.
Phoophiboon V; Brown P; Burns KEA
Can J Anaesth; 2023 Jul; 70(7):1255-1260. PubMed ID: 37349668
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra.
Loh NK; Lucas M; Fernandez S; Prentice D
Intern Med J; 2012 Dec; 42(12):1358-62. PubMed ID: 23253002
[TBL] [Abstract][Full Text] [Related]
39. Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review.
Charlesworth JEG; Kavirayani A
Eur J Haematol; 2023 Sep; 111(3):458-476. PubMed ID: 37344166
[TBL] [Abstract][Full Text] [Related]
40. Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Eloseily EM; Weiser P; Crayne CB; Haines H; Mannion ML; Stoll ML; Beukelman T; Atkinson TP; Cron RQ
Arthritis Rheumatol; 2020 Feb; 72(2):326-334. PubMed ID: 31513353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
